Nanotechnology in Drug Delivery Market 2028 By Technology, Application and Geography | The Insight Partners

report image

Nanotechnology in Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Nanoparticles, Liposomes, Nanocrystals, Micelles, Others); Application (Oncology, Cardiovascular/ Physiology, Anti-inflammatory/ Immunology, Neurology, Anti-infective, Others) and Geography

Report Code: TIPRE00024325 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET OVERVIEW

Nanotechnology is used in medicine to manipulate the molecule and develop new materials and devices. This technology is widely used to treat disease and prevent health issues. Nanotechnology in drug delivery refers to the usage of nanoscale healthcare materials and technology in pharmaceutical drug delivery to enhance drug efficacy. The drug delivery systems is utilized as diagnostic tools or to transport drugs to the specifically targeted sites in a controlled manner in the body. It is widely utilized in the healthcare industry in various applications such as neurology, cardiovascular disorders, and others.

MARKET SCOPE

The "Global Nanotechnology in Drug Delivery Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the nanotechnology in drug delivery market with detailed market segmentation by technology, application, and geography. The report provides key statistics on the market status of the leading nanotechnology in drug delivery market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on technology, the global nanotechnology in drug delivery market is segmented into nanoparticles, liposomes, nanocrystals, micelles and others.
  •  Based on application, the market is segmented into oncology, cardiovascular/ physiology, anti-inflammatory/ immunology, neurology, anti-infective and others.

MARKET DYNAMICS
Drivers:

  •  Surge in the prevalence of chronic diseases such as cancer and cardiovascular diseases.
  •  Rise in the number of deaths due to increased burden among the people.
  •  Growing advancements in nanoscale technologies.
  •  Increase in the preference for personalized medicines.
  •  Increase in R&D activities in nanotechnology to develop novel nano-medicine.

Restraints:

  •  High cost of nanotechnology drug delivery technique.
  •  Stringent government regulation.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The nanotechnology in drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the nanotechnology in drug delivery market in these regions.

IMPACT OF COVID-19ON NANOTECHNOLOGY IN DRUG DELIVERY MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The ongoing COVID-19 pandemic has impacted the worldwide economy as well as the growth of nanotechnology in the drug delivery market. Nano-based products are being developed in order to control, diagnose, and treat COVID-19. The use of multidrug nanoparticles for the targeted drug delivery can help to combat inflammation in COVID-19 patients as there is an increase in the cases, and a surge in hospitalizations can be seen, which increases the market demand. The nanotechnology used in COVID-19 has various features, including improved and virus disabling air filtration, scalable detection methods for viral particles detection, new antiviral vaccine and drug delivery platforms, and many more that enhance the growth of nanotechnology in the drug delivery market. Therefore, the pandemic has led to an increase in the market's growth.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the nanotechnology in drug delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from nanotechnology in drug delivery market are anticipated to have lucrative growth opportunities in the future with the rising demand for nanotechnology in drug delivery in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the nanotechnology in drug delivery market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  AbbVie Inc
  •  BlueWillow Biologics
  •  Pfizer
  •  Camarus AB
  •  Taiwan Liposome Co.
  •  Tarveda Therapeutics
  •  Novartis
  •  Nanobiotix
  •  NanoCarrier Co., Ltd.
  •  CytImmune Sciences Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

1. AbbVie Inc
2. BlueWillow Biologics
3. Pfizer
4. Camarus AB
5. Taiwan Liposome Co.
6. Tarveda Therapeutics
7. Novartis
8. Nanobiotix
9. NanoCarrier Co., Ltd.
10. CytImmune Sciences Inc
TIPRE00024325
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount